Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04705909
Status:
UNKNOWN
Last Update Posted:
2021-01-12
First Post:
2021-01-04
Brief Title:
Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer
Sponsor:
Mansoura University
Organization:
Mansoura University
Study Overview
Official Title:
Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer
Status:
UNKNOWN
Status Verified Date:
2021-01
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Different modalities for breast cancer treatments have exhausting and distressing side effects and toxicities leading to decreased compliance Thus repurposing drugs with accepted safety profile and possible antitumor activity becomes an eminent constraint
Statins have been reported to have possible advantages as anticancer and control of cancer progression Moreover they can sensitize cancer cells for radiotherapy Therefore the investigators aim to investigate the effect of pitavastatin added to conventional chemotherapy protocols for breast cancer patients
Statins have been reported to have possible advantages as anticancer and control of cancer progression Moreover they can sensitize cancer cells for radiotherapy Therefore the investigators aim to investigate the effect of pitavastatin added to conventional chemotherapy protocols for breast cancer patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None